Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable
Inspire Medical Systems (NASDAQ:INSP) Frequently Asked Questions
What is Inspire Medical Systems' stock symbol?
Inspire Medical Systems trades on the NASDAQ under the ticker symbol "INSP."
How were Inspire Medical Systems' earnings last quarter?
Inspire Medical Systems (NASDAQ:INSP) announced its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.32) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.45) by $0.13. The firm had revenue of $18.03 million for the quarter, compared to analyst estimates of $21.26 million. The business's revenue was up 64.9% compared to the same quarter last year. During the same period last year, the firm posted ($0.43) EPS. View Inspire Medical Systems' Earnings History.
When is Inspire Medical Systems' next earnings date?
What guidance has Inspire Medical Systems issued on next quarter's earnings?
Inspire Medical Systems updated its FY 2019 earnings guidance on Tuesday, August, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $73-75 million, compared to the consensus revenue estimate of $72.6 million.
What price target have analysts set for INSP?
4 equities research analysts have issued 1 year price objectives for Inspire Medical Systems' shares. Their predictions range from $31.00 to $75.00. On average, they anticipate Inspire Medical Systems' stock price to reach $56.75 in the next twelve months. This suggests that the stock has a possible downside of 15.1%. View Analyst Price Targets for Inspire Medical Systems.
What is the consensus analysts' recommendation for Inspire Medical Systems?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inspire Medical Systems.
Has Inspire Medical Systems been receiving favorable news coverage?
Media coverage about INSP stock has trended somewhat negative this week, according to InfoTrie. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Inspire Medical Systems earned a coverage optimism score of -1.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Inspire Medical Systems.
Who are some of Inspire Medical Systems' key competitors?
Some companies that are related to Inspire Medical Systems include ConvaTec Group (CTEC), Avita Medical (AVH), Stratec (SBS), Draegerwerk AG & Co KGaA (DRW3), Creo Medical Group (CREO), Medica Group (MGP), Hamilton Thorne (HTL), Cyclopharm (CYC), Titan Medical (TMD), Impedimed (IPD), Advanced Oncotherapy (AVO), Kromek Group (KMK), REVA Medical (RVA), MRI Interventions (MRIC) and Helius Medical Technologies (HSM).
What other stocks do shareholders of Inspire Medical Systems own?
Who are Inspire Medical Systems' key executives?
Inspire Medical Systems' management team includes the folowing people:
- Mr. Tim Herbert, Chief Exec. Officer and Pres
- Mr. Richard Buchholz, Chief Financial Officer
- Mr. Randy Ban, Sr. VP of Sales and Marketing
- Mr. Sean Cleary, VP of Global Market Devel.
- Mr. Gary A. Goetzke, VP of Health Economics
When did Inspire Medical Systems IPO?
(INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.
Who are Inspire Medical Systems' major shareholders?
Inspire Medical Systems' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Morgan Stanley (6.03%), BlackRock Inc. (5.88%), William Blair Investment Management LLC (4.88%), Invesco Ltd. (4.04%), Vanguard Group Inc. (3.33%) and Wasatch Advisors Inc. (2.86%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Casey M Tansey, Jerry C Griffin, Joyce Erony, Marilyn C Nelson, Mudit K Jain, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.
Which major investors are selling Inspire Medical Systems stock?
INSP stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, JPMorgan Chase & Co., Cormorant Asset Management LP, A.R.T. Advisors LLC, NumerixS Investment Technologies Inc, Pentwater Capital Management LP, D. E. Shaw & Co. Inc. and Jane Street Group LLC. Company insiders that have sold Inspire Medical Systems company stock in the last year include Casey M Tansey, Jerry C Griffin, Joyce Erony, Marilyn C Nelson, Mudit K Jain, Randy Ban, Richard Buchholz and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
Which major investors are buying Inspire Medical Systems stock?
INSP stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Wasatch Advisors Inc., BlackRock Inc., Columbus Circle Investors, Bamco Inc. NY, TimesSquare Capital Management LLC, Vanguard Group Inc. and Renaissance Technologies LLC. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
How do I buy shares of Inspire Medical Systems?
Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Inspire Medical Systems' stock price today?
One share of INSP stock can currently be purchased for approximately $66.81.
How big of a company is Inspire Medical Systems?
What is Inspire Medical Systems' official website?
MarketBeat Community Rating for Inspire Medical Systems (NASDAQ INSP)
MarketBeat's community ratings are surveys of what our community members think about Inspire Medical Systems and other stocks. Vote "Outperform" if you believe INSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
